A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Public ClinicalTrials.gov record NCT07218341. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Long-Term Safety of Pirtobrutinib in Participants From Study LOXO-BTK-20020 With BTKi Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Study identification
- NCT ID
- NCT07218341
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Interventions
- Idelalisib Drug
- Pirtobrutinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 8, 2026
- Primary completion
- Apr 30, 2030
- Completion
- Nov 30, 2032
- Last update posted
- Apr 16, 2026
2026 – 2032
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mitchell Cancer Institute | Mobile | Alabama | 36693 | Not yet recruiting |
| Arizona Oncology Associates, P.C. - HOPE | Tucson | Arizona | 85711 | Not yet recruiting |
| Cancer Specialists, LLC | Jacksonville | Florida | 32256 | Not yet recruiting |
| Minnesota Oncology Hematology, P.A. | Coon Rapids | Minnesota | 55433 | Not yet recruiting |
| Cayuga Cancer Center | Ithaca | New York | 14850 | Not yet recruiting |
| Memorial Sloan-Kettering Cancer Center (MSKCC) - New York | New York | New York | 10065-6007 | Not yet recruiting |
| Oncology Hematology Care Inc | Cincinnati | Ohio | 45211 | Not yet recruiting |
| Texas Oncology - Paris | Fort Worth | Texas | 76104 | Not yet recruiting |
| US Oncology - Texas Oncology | Kyle | Texas | 78640 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07218341, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07218341 live on ClinicalTrials.gov.